Molluscum Contagiosum: A viral skin disease
Pre-approval Information Exchange (PIE) Webinar
Molluscum Contagiosum: A viral skin disease
Sponsored by Verrica Pharmaceuticals Inc.
Tuesday, May 4, 2021, 2-3pm ET
Attendees will learn about molluscum contagiosum, a highly contagious viral skin disease which primarily affects children. The webinar will cover the typical clinical presentations, duration of symptoms when left untreated and why patients with atopic dermatitis are at a higher risk for developing molluscum. *
Speaker:
- Melissa Olivadoti, PhD Director, Medical Affairs from Verrica Pharmaceuticals
This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a payer with FormularyDecisionsSM.
Already a Member of FormularyDecisionsSM
To register for this webinar, log into FormularyDecisionsSM and click on the “Register” link found on the home page in the Webinars section.
Not Yet a Member of FormularyDecisionsSM
If you are a healthcare decision maker but not yet a member of FormularyDecisionsSM, you can become a member by using the “Not Registered?” link at the top of the FormularyDecisionsSM homepage. Once you are a member registered as a payer, you can click on the “Register” link found on the home page in the Webinars section. Please contact registration@formularydecisions.com for assistance registering with FormularyDecisionsSM.
*YCANTHTM is an investigational drug being reviewed by the FDA for molluscum, whose safety and efficacy has not been established. The Company resubmitted a New Drug Application (NDA) for YCANTH to the FDA on December 23, 2020. The NDA has been assigned a PDUFA goal date of June 23, 2021. This material is not intended to promote or commercialize any drug product and is supplied solely for the benefit of payers.
This PIE webinar is sponsored, developed and presented by Verrica Pharmaceuticals Inc. The content of the webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP. FormularyDecisionsSM is a leading trusted information exchange platform for a closed community of health care decision makers.
Sponsored by: